Coronavirus: Vaccination

(asked on 20th January 2021) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, for what reason the iProov-Mvine vaccine passport, which was developed with Innovate UK funding, is undertaking a trial.


Answered by
Nadhim Zahawi Portrait
Nadhim Zahawi
This question was answered on 13th April 2021

At the time of the COVID-19 Fast Start competition, launched in April 2020, the path the pandemic would follow was unclear and the Government supported every project which could aid the response, including ‘vaccine passports’. Two British companies, Mvine and iProov, were funded by Innovate UK to develop a working prototype of a vaccine passport.

The Government will review whether COVID-19 status certification could play a role in reopening the economy, reducing restrictions on social contact and improving safety. This will include assessing to what extent certification would be effective in reducing risk, and the potential uses to enable access to settings or a relaxation of COVID-19 secure mitigations. The Government will also consider the ethical, equalities, privacy, legal and operational aspects of this approach and what limits, if any, should be placed on organisations using certification. It will draw on external advice to develop recommendations that take into account any social and economic impacts and implications for disproportionately impacted groups and individuals’ privacy and security.

Reticulating Splines